Interleukin-12 and photocarcinogenesis.

Area of Science:

• Immunology
• Dermatology
• Cancer Research

Background:

• UV radiation causes skin damage, immunosuppression, and DNA damage, contributing to skin cancers.
• Interleukin-12 (IL-12) exhibits potent antitumor activity in preclinical models.

Purpose of the Study:

• To review evidence for IL-12's role in preventing photocarcinogenesis.
• To present a model for IL-12's mechanisms in photocarcinogenesis prevention.

Main Methods:

• Studies involving IL-12 treatment in mice exposed to UV radiation.
• Comparison of UV-induced tumor development in IL-12-deficient (knockout) and wild-type mice.
• Assessment of DNA damage (CPDs), sunburn cells, and tumor characteristics.

Main Results:

• IL-12 treatment prevents UV-induced immunosuppression via DNA repair.
• IL-12-deficient mice exhibit more rapid tumor development, increased tumor multiplicity and size.
• IL-12 deficiency is associated with enhanced tumor cell proliferation and higher malignant transformation rates.
• IL-12 promotes DNA repair, particularly nucleotide-excision repair, reducing UV-induced DNA damage.

Conclusions:

• Endogenous IL-12 may protect skin from UV damage, immunosuppression, and photocarcinogenesis.
• Augmenting IL-12 is a potential strategy for preventing and treating UV-induced skin cancers.